Get the Stockscreener App
308.73
0.61%
-1.89
After Hours:
308.73
Insulet Corporation stock is traded at $308.73, with a volume of 977.46K.
It is down -0.61% in the last 24 hours and down -9.16% over the past month.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
See More
Previous Close:
$310.62
Open:
$311.41
24h Volume:
977.46K
Relative Volume:
1.54
Market Cap:
$21.73B
Revenue:
$2.36B
Net Income/Loss:
$236.10M
P/E Ratio:
93.84
EPS:
3.29
Net Cash Flow:
$382.50M
1W Performance:
-5.82%
1M Performance:
-9.16%
6M Performance:
+19.32%
1Y Performance:
+32.64%
1-Day Range:
$304.64
$311.41
1-Week Range:
$304.64
$330.21
52-Week Range:
$225.37
$353.50
Insulet Corporation Stock (PODD) Company Profile
Name
Insulet Corporation
Sector
Industry
Phone
978-600-7000
Address
100 NAGOG PARK, ACTON, MA
Compare PODD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
308.73 | 21.87B | 2.36B | 236.10M | 382.50M | 3.29 |
|
ABT
Abbott Laboratories
|
133.94 | 231.67B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
97.63 | 143.79B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
369.67 | 141.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.24 | 120.53B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.77 | 45.32B | 5.69B | 1.41B | 577.90M | 6.95 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Resumed | Oppenheimer | Outperform |
| Jun-16-25 | Initiated | Truist | Buy |
| May-30-25 | Initiated | Goldman | Buy |
| May-13-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-29-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-06-25 | Initiated | RBC Capital Mkts | Outperform |
| Nov-06-24 | Initiated | Bernstein | Outperform |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-07-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-02-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-21-23 | Upgrade | Citigroup | Neutral → Buy |
| Aug-21-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-01-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-19-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Jul-28-20 | Initiated | Wells Fargo | Overweight |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-03-20 | Initiated | BofA/Merrill | Neutral |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-10-19 | Initiated | CFRA | Sell |
| Oct-23-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-14-19 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-04-19 | Downgrade | UBS | Buy → Neutral |
| Oct-03-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-06-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-10-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-06-19 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Feb-22-18 | Reiterated | Barclays | Overweight |
| Jan-08-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-03-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-15-17 | Initiated | Barclays | Overweight |
View All
Insulet Corporation Stock (PODD) Latest News
Chicago Capital LLC Has $55.92 Million Stock Holdings in Insulet Corporation $PODD - MarketBeat
How sentiment analysis helps forecast Insulet CorporationWeekly Trade Analysis & Weekly High Conviction Ideas - newser.com
Why Insulet (PODD) is a Top Growth Stock for the Long-Term - Yahoo Finance
Insulet (PODD) Sees Target Price Raised by Canaccord Genuity | P - GuruFocus
A Glimpse Into The Expert Outlook On Insulet Through 6 Analysts - Benzinga
Canaccord Genuity Maintains Insulet (PODD) Buy Recommendation - Nasdaq
Canaccord Genuity raises Insulet stock price target to $399 on T2D advantage - Investing.com India
Insulet Corporation (PODD) PT Raised to $399 at Canaccord Genuity - StreetInsider
The Mango Move: How Insulet's Colourful Strategy Is Ripe For AttentionTrademarkUnited Kingdom - Mondaq
Insulet Corporation (PODD) Stock Analysis: Healthcare Innovator with a 13.89% Upside Potential - DirectorsTalk Interviews
Is Insulet Corporation GOV a good long term investmentREITs Market Trends & Discover Your Financial Freedom Formula - earlytimes.in
Will Insulet Corporation (GOV) stock deliver stable dividends2025 Biggest Moves & Daily Risk Controlled Trade Plans - newser.com
Insulet Appoints New CFO Amid Revenue Growth - MSN
Insulet Corporation GOV Stock Analysis and ForecastEnergy Sector Updates & Affordable Investment Tips - earlytimes.in
Patton Fund Management Inc. Makes New Investment in Insulet Corporation $PODD - MarketBeat
Insulet Corporation $PODD Shares Acquired by Congress Asset Management Co. - MarketBeat
Western Financial Corp CA Makes New $1.06 Million Investment in Insulet Corporation $PODD - MarketBeat
Public Employees Retirement System of Ohio Trims Position in Insulet Corporation $PODD - MarketBeat
What drives Insulet Corporation stock priceIndustrial Stocks Review & Smart Beta Strategies That Actually Work - Early Times
Insulet Stock Surges 37.4% in 12 months: What's Driving the Rally? - Yahoo Finance
Novem Group Acquires New Holdings in Insulet Corporation $PODD - MarketBeat
Align Technology, ResMed, Insulet, Envista, and Dentsply Sirona Shares Plummet, What You Need To Know - Barchart.com
Beacon Investment Advisory Services Inc. Sells 33,261 Shares of Insulet Corporation $PODD - MarketBeat
Is Insulet Stock Outperforming The S&P 500? - Barchart.com
Mn Services Vermogensbeheer B.V. Increases Stock Position in Insulet Corporation $PODD - MarketBeat
Insulet Corporation (NASDAQ:PODD) Receives $343.06 Average Price Target from Brokerages - MarketBeat
Swedbank AB Buys 24,100 Shares of Insulet Corporation $PODD - MarketBeat
Automated Insulin Delivery Systems Market to Grow at 9.7% CAGR - openPR.com
Insulet Corporation $PODD Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Aaron Wealth Advisors LLC Acquires Shares of 925 Insulet Corporation $PODD - MarketBeat
Alecta Tjanstepension Omsesidigt Purchases 61,500 Shares of Insulet Corporation $PODD - MarketBeat
Strs Ohio Invests $1 Million in Insulet Corporation $PODD - MarketBeat
Czech National Bank Purchases 1,091 Shares of Insulet Corporation $PODD - MarketBeat
3,137 Shares in Insulet Corporation $PODD Bought by Marshall Financial Group LLC - MarketBeat
Insulet Corporation Stock (PODD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Insulet Corporation Stock (PODD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Singh Prem | SVP, Global Operations |
Sep 08 '25 |
Sale |
347.49 |
687 |
238,726 |
3,456 |
| Cousin Laetitia | SVP, Reg, Quality & Compliance |
Sep 08 '25 |
Option Exercise |
241.10 |
797 |
192,160 |
4,687 |
| Cousin Laetitia | SVP, Reg, Quality & Compliance |
Sep 08 '25 |
Sale |
348.81 |
797 |
278,002 |
3,890 |
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):